← Leaderboards
Saeed Rehman Khan
Johns Hopkins University
$1,441,162
Attributed
$1,441,162
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.3K · FY2005–10$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,441,162 · 2
By mechanism
K01$770,571 · 1
P30$670,591 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert N Cole$2,029,196
- Richard D Schulick$14,841,770
- Manuel Hidalgo$7,987,249
- Drew M. Pardoll$27,059,898
- Sergei Zolotukhin$5,763,792
Others in their field
Top investigators on “Prodrugs”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Robert Turner Schooley · University Of Colorado Denver$47,231,917
- Lynn Kirkpatrick · Ensysce Biosciences, Inc.$26,039,397
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Kevin V Grimes · Stanford University$14,783,804
Research focus
ProdrugsFeedingAreaDrug DevelopmentEquipmentEvaporationCost SharingCustomDocumentationDrug CompoundingAnticancer ResearchCancer Center Support GrantBiochemicalChemical SynthesisDesignCostChromatin StructureAntineoplastic AgentsBiomedical ResearchColumn ChromatographyArtsCommunitiesContractsEquilibrium
Grant awards (11)
MEDICINAL CHEMISTRY$172,865
P30 · FY2010 · CA · contact PI
MEDICINAL CHEMISTRY$175,241
P30 · FY2009 · CA · contact PI
MEDICINAL CHEMISTRY$69,090
P30 · FY2009 · CA · contact PI
MEDICINAL CHEMISTRY$84,465
P30 · FY2008 · CA · contact PI
MEDICINAL CHEMISTRY$84,465
P30 · FY2007 · CA · contact PI
Novel Drug Development for Prostatic Cancer$158,490
K01 · FY2006 · CA · contact PI
MEDICINAL CHEMISTRY$84,465
P30 · FY2006 · CA · contact PI
Novel Drug Development for Prostatic Cancer$158,490
K01 · FY2005 · CA
Novel Drug Development for Prostatic Cancer$158,490
K01 · FY2004 · CA
Novel Drug Development for Prostatic Cancer$158,490
K01 · FY2003 · CA
Novel Drug Development for Prostatic Cancer$136,611
K01 · FY2002 · CA